Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 65 of 65 entries
View as:

Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003352 Org: User:
Start: 06/30/98 End: 12/31/02 Due: 12/31/03

Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum

Phase: N/A Priority: Normal
NCT ID: NCT00346099 Org: User:
Start: 06/30/06 End: 05/31/07 Due: 05/31/08

A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02296801 Org: User:
Start: 01/31/15 End: 03/31/19 Due: 03/31/20

Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00321828 Org: User:
Start: 03/31/06 End: 12/31/12 Due: 12/31/13

Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32

Phase: N/A Priority: Normal
NCT ID: NCT01286233 Org: User:
Start: 07/31/11 End: 09/30/16 Due: 09/30/17

Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01008150 Org: User:
Start: 10/31/10 End: 11/25/16 Due: 11/25/17

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00003906 Org: User:
Start: 05/31/99 End: 08/31/12 Due: 08/31/13

Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03102047 Org: User:
Start: 05/14/18 End: 12/30/21 Due: 12/30/22

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00009945 Org: User:
Start: 01/31/01 End: 12/31/12 Due: 12/31/13

A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02236000 Org: User:
Start: 08/31/14 End: 08/31/21 Due: 08/31/22

Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

Phase: N/A Priority: Normal
NCT ID: NCT00967239 Org: User:
Start: 04/30/09 End: - Due: -

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00410579 Org: User:
Start: 11/30/06 End: 02/28/09 Due: 02/28/10

Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03007407 Org: User:
Start: 07/31/17 End: 08/09/19 Due: 08/09/20

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00382070 Org: User:
Start: 08/31/06 End: 04/30/25 Due: 04/30/26

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00053898 Org: User:
Start: 01/31/03 End: 05/31/16 Due: 05/31/17